Physician profile
Douglas Hadley
NPI 1902984776
$691.83
in general payments reported to CMS, 2019-2025
14 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.01 · 2022: $11.65 · 2023: $367 · 2024: $104 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $642.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $157.60 | 2024-2025 | Indigo System |
| Boston Scientific Corporation | $116.92 | 2023 | |
| Janssen Biotech, INC. | $80.88 | 2023-2024 | Tecvayli, Darzalex, Imbruvica |
| Trisalus Life Sciences, INC. | $80.83 | 2025 | Trinav Infusion System |
| Lilly USA, LLC | $61.69 | 2023 | Verzenio, Retevmo, Jaypirca |
| Cook Medical LLC | $38.01 | 2019 | |
| Siemens Medical Solutions USA, INC. | $26.31 | 2022-2023 | Microthermx Microwave Ablation System |
| Pharming Healthcare, INC. | $25.34 | 2023 | Ruconest |
| Seagen INC. | $23.82 | 2023 | Adcetris |
| Bard Peripheral Vascular, INC. | $18.03 | 2024 | Venovo |
| Hologic Sales and Service, LLC | $16.51 | 2023 | Aixplorer Ultimate |
| Recordati_rare_diseases_inc. | $16.09 | 2023 | Sylvant |
| Medtronic, INC. | $15.05 | 2023 | Osteocool Rf Ablation System |
| Biogen, INC. | $14.75 | 2023 | Spinraza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Hadley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.